FRESENIUS MEDICAL CARE-ADR
FMSNYSE🏆 #725 by market capEarnings Nov 3US Equity
$23.64▼ $0.23 (−0.96%)
Live1h▼ 0.2%
24h▼ 1.0%
7d▼ 1.1%
14d▼ 5.0%
30d▼ 3.3%
1y▼ 2.4%
🏦Market Cap
$12.70B
Mid Cap
📈Revenue Growth (YoY)
+1.5%
Slowing
📊Gross Margin
26.4%
Moderate
💵FCF Margin
9.2%
Moderate
⚖️P/S Ratio
0.6x
Cheap
Otter Score
57
Weak
📊
Analyst Ratings
Price
$23.64
Total
20
Raised
6
Lowered
9
Avg PT
$23.57
H / L
$26 / $20
| Institution | Action | Rating | Date |
|---|---|---|---|
Goldman Sachs | Downgraded | Buy → Neutral | 2026-01-20 |
B of A Securities | Downgraded | Neutral → Underperform | 2025-10-15 |
UBS | Downgraded | Neutral → Sell | 2025-09-02 |
Truist Securities | Reiterated | Hold | 2025-05-12 |
HSBC | Upgraded | Reduce → Hold | 2023-11-24 |
RBC Capital | Reiterated | Sector Perform | 2021-11-17 |
Jefferies | Upgraded | Underperform → Hold | 2021-11-11 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-05-21 |
CFRA | Upgraded | Hold → Buy | 2020-02-21 |
Redburn Partners | Downgraded | Buy → Neutral | 2019-10-23 |
Redburn | Downgraded | Buy → Neutral | 2019-10-23 |
BTIG | Downgraded | Buy → Neutral | 2019-08-01 |
Barclays | Upgraded | Equal Weight → Overweight | 2019-06-20 |
DZ Bank | Downgraded | Buy → Hold | 2018-10-18 |
Deutsche Bank | Upgraded | Hold → Buy | 2018-04-24 |
Piper Sandler | Reiterated | Neutral | 2015-10-30 |
PiperJaffray | Reiterated | Neutral | 2015-10-30 |
Societe Generale | Downgraded | Buy → Hold | 2015-08-13 |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2013-12-02 |
Exane BNP Paribas | Downgraded | Outperform → Neutral | 2013-07-03 |
One row per institution, most recent rating